FocusOn Neurology
  • Biozone
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • Myasthenia Gravis
  • Neurofibromatosis
  • hATTR-PN
  • MDA 2024
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights
  • Parkinson's Disease
  • AES Annual Meeting 2025
  • Epilepsy Awareness Month
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • Myasthenia Gravis
  • Neurofibromatosis
  • hATTR-PN
  • MDA 2024
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights
  • Parkinson's Disease
    • Peer-reviewed articles
    • Supplemental educational content
    • Test Your Knowledge
  • Epilepsy Awareness Month

Advanced Search

Advanced Search

  • Featured:
  • Biozone
  • AES Annual Meeting 2025
BioZone
  • Overview
  • Intro to biosimilars  
    • An introduction to biosimilar medicines
    • The clinical development process of biosimilar medicines
    • The 15-year rise of biosimilar medicines
    • Biosimilars: Basics and beyond
    • Understanding biologics: A guide to reference and biosimilar biologic medicines training deck
    • Exploring biologic and biosimilar medicines and how they differ from other medicine classes
    • Turning a new page in multiple sclerosis
    • Demystifying the language of biologic and biosimilar medicines: A glossary
  • Value of biosimilars  
    • Biosimilar success case studies digital map
    • A biosimilar future: Lessons from other therapy areas
    • Unmet needs in treatment access for multiple sclerosis training deck
    • Illuminoz talks™: Biosimilars conversations with European leading experts
  • Important considerations for biosimilars  
    • The nocebo effect: Implications for biosimilar medicines
    • Biosimilar medicine treatment: Insights into HCP-patient conversations
    • Immunogenicity in the context of biologic medicines
    • Everything neurologists need to know
    • An introduction to biosimilar medicines: Pocket guide
  • Quiz
FocusOn logo
  • Articles
  • Multimedia
  • Blog
  • Resources
  • About FocusOn
  • Privacy Policy
  • Terms of Use

© 2026 Wolters Kluwer. All right reserved.

Are you a healthcare professional?

The information on this website is intended for healthcare professionals only and is not intended for the public. Please select the option that applies to you.

By choosing one of the healthcare professional options , you confirm this statement is true and you accept all liability related to the above. This website is providing educational medical information on biosimilars and does not contain nor is intended to provide or replace any medical advice.

Was this website helpful? Take our short survey and help us improve

Cookie Consent

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them please read our Privacy and Cookie Policy.

|
|

Cookie Policy

Information about our use of cookies

Wolters Kluwer ("we" or "us") wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain what personal information we collect, use and disclose.

Personal information means any data relating to an individual who can be identified, directly or indirectly, based on that information. This may include information such as names, contact details, (online) identification data, online identifiers, or other characteristics specific to that individual.

Read More